Clinical Trials
7
Active:0
Completed:6
Trial Phases
4 Phases
Phase 1:1
Phase 2:4
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 2
4 (57.1%)Not Applicable
1 (14.3%)Phase 1
1 (14.3%)Phase 4
1 (14.3%)Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea
Phase 2
- Conditions
- Papulopustular Rosacea
- Interventions
- Drug: topical gel vehicle
- First Posted Date
- 2018-09-12
- Last Posted Date
- 2019-07-10
- Lead Sponsor
- BioPharmX, Inc.
- Target Recruit Count
- 207
- Registration Number
- NCT03667222
- Locations
- 🇺🇸
Study Center, San Antonio, Texas, United States
Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea
Phase 1
Completed
- Conditions
- Moderate to Severe Papulopustular Rosacea
- Interventions
- Drug: BPX-04 vehicle topical gelDrug: BPX-04 1% minocycline topical gelDrug: BPX-04 2% minocycline topical gel
- First Posted Date
- 2017-02-10
- Last Posted Date
- 2019-01-31
- Lead Sponsor
- BioPharmX, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03050086
- Locations
- 🇺🇸
Study Center, San Diego, California, United States
Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel
- First Posted Date
- 2016-10-27
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- BioPharmX, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02946788
- Locations
- 🇺🇸
Study Center, Las Vegas, Nevada, United States
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
Phase 2
Completed
- Conditions
- Acne Vulgaris
- Interventions
- Drug: BPX-01 Vehicle Topical GelDrug: BPX-01 1% Minocycline Topical GelDrug: BPX-01 2% Minocycline Topical Gel
- First Posted Date
- 2016-06-28
- Last Posted Date
- 2017-04-14
- Lead Sponsor
- BioPharmX, Inc.
- Target Recruit Count
- 225
- Registration Number
- NCT02815332
BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes
Phase 2
Completed
- Conditions
- Acne Vulgaris
- Interventions
- Drug: BPX-01, 1% Topical GelDrug: BPX-01 Vehicle Gel
- First Posted Date
- 2016-03-15
- Last Posted Date
- 2017-09-14
- Lead Sponsor
- BioPharmX, Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT02709096
- Locations
- 🇺🇸
KGL Skin Study Center, Broomall, Pennsylvania, United States
- Prev
- 1
- 2
- Next
News
No news found